NCT06437210Completed
Evaluation of Treatment With Viusid in Post-COVID-19 Syndrome
Source: ClinicalTrials.gov · Last updated 3 Jun 2024
Brief summary (registry, in English)
Reports of long-lasting symptoms of COVID-19 are increasing, but little is known about the prevalence of risk factors or whether it is possible to predict a prolonged course at disease onset. Prolonged COVID is characterized on the basis of symptoms such as fatigue, headache, dyspnea, and anosmia present for weeks, with older age, high body mass index, and female sex being more susceptible. Accordingly, and in the absence of specific treatments, the present study seeks to establish a treatment protocol for Post-COVID syndrome through the application of the dietary supplement VIUSID, due to its anti-inflammatory and immunomodulatory effect, thus helping to reduce and/or control the symptoms of the syndrome.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 200 (actual)
- First submitted
- 30 May 2024
- Start date
- 15 Feb 2022
- Primary completion date
- 15 Dec 2023
- Lead sponsor
- Catalysis SL
- Diseases
- Long COVID and ME/CFS
- NCT number
- NCT06437210
What you commit to
- Study type: Interventional
- Participants enrolled: 200
- From 15 Feb 2022 to the primary completion date, 15 Dec 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients who have presented symptoms similar to Post-COVID syndrome prior to the onset of COVID-19 due to a concomitant disease.
Other illness
- Patients with a positive diagnosis of COVID-19 in the last 14 days.
Who the study is looking for
- Patients with one or more of the following symptoms, persistent after suffering COVID-19:
- Extreme tiredness (Fatigue).
- Shortness of breath
- Chest pain
- Problems with memory or concentration ("Brain fog")
- Insomnia
- Palpitations
- Dizziness
- Tingling
- Joint pain
- Depression and anxiety
- Tinnitus or ear pain
- Malaise, diarrhea, stomach pain, loss of appetite
- Fever, cough, headache, dry throat, changes in sense of smell or taste
- Rash
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Fundación CR INVESTIGATION INSTITUTE Coordinator of this site? Confirm its status | Bogotá | Colombia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.